Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

About this update from Champions Oncology, Inc.

HACKENSACK, NJ / ACCESSWIRE / July 20, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the fourth quarter and year ended April 30, 2023 , on Monday, July 24, 2023 , after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT ( 1:30 P.M. PDT ). To join the call dial 877-545-0523 (Domestic) or 973-528-0016 (International) and enter the access code 477670. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 48774, or by accessing the investors section of the company's website within 72 hours. About Champions Oncology, Inc. Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com . SOURCE: Champions Oncology, Inc. View source version on accesswire.com : https://www.accesswire.com/769392/Champions-Oncology-to-Announce-Fourth-Quarter-and-Year-End-Financial-Results-on-Monday-July-24-2023

View stock analysis, news, and events for Champions Oncology, Inc.